Comparison between hypersensitivity reactions to cycles of modified FOLFOX6 and XELOX therapies in patients with colorectal cancer-Reference-Cited by-同舟云学术

Comparison between hypersensitivity reactions to cycles of modified FOLFOX6 and XELOX therapies in patients with colorectal cancer

Published:2017-04-08 Issue:5 Volume:79 Page:1021-1029
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Ohta Hideki,Hayashi Takahiro^ORCID,Murai Sumie,Shiouchi Hideyo,Ando Yosuke,Kumazawa Satomi,Ito Kaori,Ikeda Yoshiaki,Matsuoka Hiroshi,Maeda Kotaro,Kawada Kenji,Yasuda Kimio,Yamada Shigeki

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-017-3294-9.pdf

Reference28 articles.

1. de Gramont A, Figer A, Seymour M et al (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18:2938–2947

2. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. Colon/Rectal Cancer, 2015 ver.2. https://www.nccn.org/professionals/physician_gls/f_guidelines.asp . Accessed 2 Dec 2016

3. Watanabe T, Itabashi M, Shimada Y et al (2015) Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol 20:207–239

4. Makrilia N, Syrigou E, Kaklamanos I et al (2010) Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review. Met Based Drugs. doi: 10.1155/2010/207084

5. Brandi G, Pantaleo MA, Galli C et al (2003) Hypersensitivity reactions related to oxaliplatin (OHP). Br J Cancer 89:477–481

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-dose oxaliplatin induces severe hypersensitivity reactions and high recurrence rates during rechallenge in patients treated with hepatic arterial infusion chemotherapy;International Immunopharmacology;2024-03

2. Clinical characteristics and risk factors for oxaliplatin hypersensitivity reactions in patients with colorectal cancer;Journal of Oncology Pharmacy Practice;2023-12-12

3. Incidence of oxaliplatin hypersensitivity reaction among colorectal cancer patients: A 5-year retrospective study;Pharmacy Practice;2022-07-10

4. Safety Profile of Oxaliplatin in 3,687 Patients With Cancer in China: A Post-Marketing Surveillance Study;Frontiers in Oncology;2021-10-21

5. Meta-analysis of risk factors associated with oxaliplatin hypersensitivity reactions in cancer patients;International Journal of Clinical Oncology;2021-10-09